In this section, we have gathered all the key news related to the company – press releases, upcoming events, initiatives, and awards – as well as topics of interest in the world of Artificial Intelligence.
In recent years, synbrAIn has made significant strides in the field of Digital Healthcare, developing numerous AI and machine learning-driven solutions to support medical diagnostics. Within this framework, a strong collaboration has emerged with EMME ESSE, a company with over 40 years of…
After four years of continuous collaboration, synbrAIn has acquired one of its key business partners: SenticLab. Founded in April 2017 in Iași, Northeastern Romania, SenticLab quickly established itself as a research-focused company, strengthened by its strong ties to the academic and university environment.…
MIA-COV19D is an international competition organized by the University of Lincoln (UK), aimed at developing new solutions for identifying COVID-19-related diseases through the analysis of lung CT images. The competition was held as part of ICCV 2021, one of the world’s leading scientific…
As we announced a few weeks ago, the launch of MS humanAId by Emme Esse has seen synbrAIn's active involvement in developing a system that leverages artificial intelligence to support diagnostic image analysis. Specifically, the development of the AID CHEST XR PNEUMO module…
The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling its deployment in additional hospitals across Lombardy. With MS humanAId, radiologists will have access to a range…
ImageCLEF is an international initiative organized by the CLEF initiative lab, aimed at fostering the development of new AI and machine learning-based solutions to address challenges in the healthcare and medical domains. This year’s edition focused on developing the best possible solution for…
Among the various collaborations initiated by synbrAIn, one stands out as particularly significant in the healthcare sector: its partnership with Emme Esse. Emme Esse is a company with over 40 years of experience in developing electronic solutions across various industries, including healthcare, specializing…
synbrAIn was born in 2019 from the merger of GetLeads and Arcaspark. Since then, the company has been experiencing constant growth in terms of personnel, know-how, and overall economic and corporate stability. For this reason, in recent days, the company took the opportunity…
Lung cancer is a severe disease that leads to a high number of fatalities. Among all types of cancer, it is the leading cause of cancer-related deaths worldwide. The symptoms of lung cancer typically appear in advanced stages, when treatment options are less…
As part of its ongoing commitment to innovation, the synbrAIn team has launched AIDE-X, an acronym for Artificial Intelligence for Early Detection of Lung Diseases from Chest X-ray Images. AIDE-X is a research project aimed at supporting pneumonia detection while also identifying its…